InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+20.4%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by ANSTICE DAVID W, Director. Director active across 1 company, notably Alkermes plc.. Cumulatively, 9 filings have been logged. History available since 20 May 2021. The latest transaction was disclosed on 1 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
7,585 sharesOrdinary SharesSEC:0001127602-22-017632:0
5,578 sharesOrdinary SharesSEC:0001127602-21-030300:0
5,578 sharesOrdinary SharesSEC:0001127602-21-030300
20,000 shares@ US$14.6040.2% of flowOrdinary SharesSEC:0001127602-21-021239
20,000 shares@ US$14.600.0053% mcap40.2% of flowOrdinary SharesSEC:0001127602-21-021239:0
5,000 shares@ US$14.600.0013% mcap9.8% of flowOrdinary SharesSEC:0001127602-21-019456:0
5,000 shares@ US$14.609.8% of flowOrdinary SharesSEC:0001127602-21-019456
6,104 shares0Ordinary SharesSEC:0001127602-21-017782
6,104 shares0Ordinary SharesSEC:0001127602-21-017782:0
9 of 9 declarations
About ANSTICE DAVID W
David W. Anstice is a Board Member at Alkermes plc. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing operations. Alkermes is a biopharmaceutical company specializing in the development of treatments for psychiatric diseases. Mr. Anstice's experience in the pharmaceutical sector is an asset for the company.
